StemSynergy Therapeutics, Inc.的封面图片
StemSynergy Therapeutics, Inc.

StemSynergy Therapeutics, Inc.

生物技术

Miami，FL 574 位关注者

Stem Cell Research Drives Innovative Cancer Therapeutics

关注

关于我们

StemSynergy Therapeutics, Inc. (SSTI) is a biotechnology company focused on discovering drugs that target biomolecules and cellular processes fundamental to cancer. We target the cancer stem/initiating cell (CSC) populations, with the overall aim of eliminating tumor growth. We have two patents awarded and one patent pending for breakthrough technologies in modulating cancer stem cell pathways, such as those driven by Wnt, Notch, and Sonic Hedgehog (Shh) signaling. With a multi-pronged scientific approach and a number of agents targeting these pathways, SSTI is well positioned to address critical unmet needs in cancer treatment.

网站
https://www.stemsynergy.com
所属行业
生物技术
规模
2-10 人
总部
Miami，FL
类型
私人持股
领域
Cancer Therapeutics、Regenerative Medicine、Medicinal Chemistry、Cellular and Molecular Biology、Pharmaceutical和Biotechnology

地点

  • 主要

    1951 NW 7th Avenue

    Suite 300

    US，FL，Miami，33136

    获取路线

  • 393 Nichol Mill Lane

    Suite 12

    US，TN，Franklin，37067

    获取路线

StemSynergy Therapeutics, Inc.员工

查看全部员工

相似主页

查看职位